nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—hypertension	0.122	0.299	CbGaD
Minocycline—ALOX5—hypertension	0.111	0.272	CbGaD
Minocycline—VEGFA—Carvedilol—hypertension	0.102	0.265	CbGbCtD
Minocycline—MMP9—Captopril—hypertension	0.0926	0.241	CbGbCtD
Minocycline—VEGFA—hypertension	0.0892	0.218	CbGaD
Minocycline—MMP9—hypertension	0.0863	0.211	CbGaD
Minocycline—SLC22A7—Enalapril—hypertension	0.0223	0.0581	CbGbCtD
Minocycline—SLC22A11—Bumetanide—hypertension	0.0219	0.057	CbGbCtD
Minocycline—SLC22A7—Bumetanide—hypertension	0.0208	0.0543	CbGbCtD
Minocycline—SLC22A6—Ethacrynic acid—hypertension	0.0151	0.0394	CbGbCtD
Minocycline—SLC22A6—Chlorothiazide—hypertension	0.0151	0.0394	CbGbCtD
Minocycline—SLC22A11—Furosemide—hypertension	0.0141	0.0367	CbGbCtD
Minocycline—SLC22A8—Enalapril—hypertension	0.0136	0.0355	CbGbCtD
Minocycline—SLC22A8—Bumetanide—hypertension	0.0127	0.0331	CbGbCtD
Minocycline—SLC22A6—Enalapril—hypertension	0.00949	0.0247	CbGbCtD
Minocycline—SLC22A6—Hydrochlorothiazide—hypertension	0.00906	0.0236	CbGbCtD
Minocycline—SLC22A6—Bumetanide—hypertension	0.00886	0.0231	CbGbCtD
Minocycline—SLC22A8—Furosemide—hypertension	0.0082	0.0213	CbGbCtD
Minocycline—CASP3—middle cerebral artery—hypertension	0.00719	0.0993	CbGeAlD
Minocycline—SLC22A6—Captopril—hypertension	0.00711	0.0185	CbGbCtD
Minocycline—SLC22A6—Furosemide—hypertension	0.00571	0.0149	CbGbCtD
Minocycline—SLC22A6—Losartan—hypertension	0.00559	0.0146	CbGbCtD
Minocycline—MMP9—middle cerebral artery—hypertension	0.00479	0.0661	CbGeAlD
Minocycline—MMP9—tunica intima—hypertension	0.00299	0.0414	CbGeAlD
Minocycline—CASP3—nephron—hypertension	0.00276	0.0381	CbGeAlD
Minocycline—IL1B—nephron—hypertension	0.0022	0.0304	CbGeAlD
Minocycline—IL1B—hindlimb—hypertension	0.002	0.0277	CbGeAlD
Minocycline—MMP9—hindlimb—hypertension	0.00167	0.0231	CbGeAlD
Minocycline—CASP3—artery—hypertension	0.00154	0.0213	CbGeAlD
Minocycline—CYCS—blood vessel—hypertension	0.0014	0.0193	CbGeAlD
Minocycline—CASP3—endothelium—hypertension	0.0013	0.018	CbGeAlD
Minocycline—IL1B—artery—hypertension	0.00123	0.017	CbGeAlD
Minocycline—CASP3—blood vessel—hypertension	0.0012	0.0166	CbGeAlD
Minocycline—Doxycycline—MMP7—hypertension	0.0011	0.558	CrCbGaD
Minocycline—IL1B—endothelium—hypertension	0.00104	0.0143	CbGeAlD
Minocycline—MMP9—artery—hypertension	0.00102	0.0142	CbGeAlD
Minocycline—SLC22A8—nephron—hypertension	0.000981	0.0136	CbGeAlD
Minocycline—IL1B—blood vessel—hypertension	0.000957	0.0132	CbGeAlD
Minocycline—CYCS—myocardium—hypertension	0.000947	0.0131	CbGeAlD
Minocycline—MMP9—endothelium—hypertension	0.000865	0.012	CbGeAlD
Minocycline—CASP3—cardiac ventricle—hypertension	0.000863	0.0119	CbGeAlD
Minocycline—CASP3—myocardium—hypertension	0.000812	0.0112	CbGeAlD
Minocycline—MMP9—blood vessel—hypertension	0.000798	0.011	CbGeAlD
Minocycline—SLC22A8—urine—hypertension	0.000787	0.0109	CbGeAlD
Minocycline—CYCS—brainstem—hypertension	0.000765	0.0106	CbGeAlD
Minocycline—CASP1—heart—hypertension	0.000687	0.0095	CbGeAlD
Minocycline—VEGFA—cardiac ventricle—hypertension	0.000678	0.00937	CbGeAlD
Minocycline—CASP1—decidua—hypertension	0.000668	0.00923	CbGeAlD
Minocycline—CYCS—heart—hypertension	0.000661	0.00914	CbGeAlD
Minocycline—CYCS—smooth muscle tissue—hypertension	0.000656	0.00907	CbGeAlD
Minocycline—CASP3—brainstem—hypertension	0.000655	0.00905	CbGeAlD
Minocycline—IL1B—myocardium—hypertension	0.000648	0.00896	CbGeAlD
Minocycline—CASP1—cardiovascular system—hypertension	0.000648	0.00896	CbGeAlD
Minocycline—VEGFA—myocardium—hypertension	0.000638	0.00881	CbGeAlD
Minocycline—CASP1—kidney—hypertension	0.000634	0.00877	CbGeAlD
Minocycline—CYCS—cardiovascular system—hypertension	0.000624	0.00862	CbGeAlD
Minocycline—CASP1—cortex of kidney—hypertension	0.000618	0.00854	CbGeAlD
Minocycline—CYCS—kidney—hypertension	0.000611	0.00844	CbGeAlD
Minocycline—CASP3—nephron tubule—hypertension	0.000595	0.00822	CbGeAlD
Minocycline—CASP3—adrenal cortex—hypertension	0.000586	0.00809	CbGeAlD
Minocycline—Doxycycline—MMP1—hypertension	0.000578	0.293	CrCbGaD
Minocycline—CASP3—heart—hypertension	0.000566	0.00783	CbGeAlD
Minocycline—CASP3—smooth muscle tissue—hypertension	0.000562	0.00777	CbGeAlD
Minocycline—CASP3—decidua—hypertension	0.000551	0.00761	CbGeAlD
Minocycline—MMP9—myocardium—hypertension	0.00054	0.00747	CbGeAlD
Minocycline—CASP3—cardiovascular system—hypertension	0.000535	0.00739	CbGeAlD
Minocycline—IL1B—brainstem—hypertension	0.000523	0.00723	CbGeAlD
Minocycline—CASP3—kidney—hypertension	0.000523	0.00723	CbGeAlD
Minocycline—CASP1—adrenal gland—hypertension	0.000513	0.00709	CbGeAlD
Minocycline—CYCS—adrenal gland—hypertension	0.000494	0.00682	CbGeAlD
Minocycline—VEGFA—nephron tubule—hypertension	0.000468	0.00646	CbGeAlD
Minocycline—VEGFA—adrenal cortex—hypertension	0.00046	0.00636	CbGeAlD
Minocycline—CASP3—medulla oblongata—hypertension	0.000457	0.00631	CbGeAlD
Minocycline—IL1B—heart—hypertension	0.000453	0.00625	CbGeAlD
Minocycline—IL1B—smooth muscle tissue—hypertension	0.000449	0.0062	CbGeAlD
Minocycline—VEGFA—heart—hypertension	0.000445	0.00615	CbGeAlD
Minocycline—CASP1—endocrine gland—hypertension	0.000445	0.00615	CbGeAlD
Minocycline—VEGFA—smooth muscle tissue—hypertension	0.000442	0.0061	CbGeAlD
Minocycline—VEGFA—Timolol—Penbutolol—hypertension	0.00044	0.147	CbGdCrCtD
Minocycline—IL1B—decidua—hypertension	0.00044	0.00608	CbGeAlD
Minocycline—VEGFA—decidua—hypertension	0.000433	0.00598	CbGeAlD
Minocycline—CYCS—endocrine gland—hypertension	0.000428	0.00592	CbGeAlD
Minocycline—IL1B—cardiovascular system—hypertension	0.000427	0.0059	CbGeAlD
Minocycline—CASP3—adrenal gland—hypertension	0.000423	0.00584	CbGeAlD
Minocycline—IL1B—kidney—hypertension	0.000418	0.00577	CbGeAlD
Minocycline—CASP1—central nervous system—hypertension	0.000401	0.00554	CbGeAlD
Minocycline—VEGFA—cortex of kidney—hypertension	0.0004	0.00553	CbGeAlD
Minocycline—CYCS—central nervous system—hypertension	0.000386	0.00533	CbGeAlD
Minocycline—VEGFA—cardiac atrium—hypertension	0.000381	0.00526	CbGeAlD
Minocycline—MMP9—heart—hypertension	0.000377	0.00521	CbGeAlD
Minocycline—SLC22A11—nephron tubule—hypertension	0.000376	0.00519	CbGeAlD
Minocycline—MMP9—smooth muscle tissue—hypertension	0.000374	0.00517	CbGeAlD
Minocycline—MMP9—decidua—hypertension	0.000367	0.00507	CbGeAlD
Minocycline—CASP3—endocrine gland—hypertension	0.000367	0.00507	CbGeAlD
Minocycline—IL1B—medulla oblongata—hypertension	0.000365	0.00504	CbGeAlD
Minocycline—MMP9—cardiovascular system—hypertension	0.000356	0.00492	CbGeAlD
Minocycline—SLC22A6—nephron tubule—hypertension	0.000354	0.00489	CbGeAlD
Minocycline—MMP9—kidney—hypertension	0.000348	0.00481	CbGeAlD
Minocycline—IL1B—adrenal gland—hypertension	0.000338	0.00467	CbGeAlD
Minocycline—VEGFA—adrenal gland—hypertension	0.000332	0.00459	CbGeAlD
Minocycline—CASP3—central nervous system—hypertension	0.00033	0.00457	CbGeAlD
Minocycline—SLC22A11—kidney—hypertension	0.00033	0.00456	CbGeAlD
Minocycline—SLC22A7—kidney—hypertension	0.000322	0.00445	CbGeAlD
Minocycline—SLC22A11—cortex of kidney—hypertension	0.000321	0.00444	CbGeAlD
Minocycline—SLC22A7—cortex of kidney—hypertension	0.000314	0.00434	CbGeAlD
Minocycline—SLC22A6—cortex of kidney—hypertension	0.000303	0.00419	CbGeAlD
Minocycline—ALOX5—heart—hypertension	0.000298	0.00412	CbGeAlD
Minocycline—ALOX5—smooth muscle tissue—hypertension	0.000296	0.00409	CbGeAlD
Minocycline—IL1B—endocrine gland—hypertension	0.000293	0.00405	CbGeAlD
Minocycline—ALOX5—decidua—hypertension	0.00029	0.00401	CbGeAlD
Minocycline—MMP9—adrenal gland—hypertension	0.000281	0.00389	CbGeAlD
Minocycline—ALOX5—cardiovascular system—hypertension	0.000281	0.00389	CbGeAlD
Minocycline—CYCS—Diazoxide—Chlorothiazide—hypertension	0.000265	0.0884	CbGdCrCtD
Minocycline—IL1B—central nervous system—hypertension	0.000264	0.00365	CbGeAlD
Minocycline—CYCS—Captopril—Enalapril—hypertension	0.000257	0.0857	CbGdCrCtD
Minocycline—MMP9—endocrine gland—hypertension	0.000244	0.00337	CbGeAlD
Minocycline—SLC22A11—endocrine gland—hypertension	0.000231	0.0032	CbGeAlD
Minocycline—SLC22A7—endocrine gland—hypertension	0.000226	0.00312	CbGeAlD
Minocycline—ALOX5—adrenal gland—hypertension	0.000223	0.00308	CbGeAlD
Minocycline—CYCS—Papaverine—Verapamil—hypertension	0.000222	0.074	CbGdCrCtD
Minocycline—MMP9—central nervous system—hypertension	0.00022	0.00304	CbGeAlD
Minocycline—SLC22A8—nephron tubule—hypertension	0.000212	0.00293	CbGeAlD
Minocycline—VEGFA—Enalapril—Captopril—hypertension	0.000205	0.0685	CbGdCrCtD
Minocycline—Methacycline—ALB—hypertension	0.000204	0.104	CrCbGaD
Minocycline—ALOX5—endocrine gland—hypertension	0.000193	0.00267	CbGeAlD
Minocycline—SLC22A8—kidney—hypertension	0.000186	0.00257	CbGeAlD
Minocycline—SLC22A8—cortex of kidney—hypertension	0.000181	0.00251	CbGeAlD
Minocycline—ALOX5—central nervous system—hypertension	0.000174	0.0024	CbGeAlD
Minocycline—VEGFA—Enalapril—Fosinopril—hypertension	0.000146	0.0488	CbGdCrCtD
Minocycline—VEGFA—Enalapril—Moexipril—hypertension	0.000127	0.0423	CbGdCrCtD
Minocycline—CYCS—Fluvastatin—Atorvastatin—hypertension	0.000122	0.0406	CbGdCrCtD
Minocycline—SLC22A8—central nervous system—hypertension	0.000118	0.00163	CbGeAlD
Minocycline—VEGFA—Enalapril—Perindopril—hypertension	0.000111	0.037	CbGdCrCtD
Minocycline—VEGFA—Enalapril—Quinapril—hypertension	0.000105	0.0351	CbGdCrCtD
Minocycline—VEGFA—Enalapril—Benazepril—hypertension	0.000103	0.0342	CbGdCrCtD
Minocycline—CYCS—Alimemazine—Diltiazem—hypertension	0.000101	0.0336	CbGdCrCtD
Minocycline—CYCS—Pitavastatin—Atorvastatin—hypertension	9.94e-05	0.0332	CbGdCrCtD
Minocycline—VEGFA—Pindolol—Nadolol—hypertension	9.06e-05	0.0302	CbGdCrCtD
Minocycline—Tetracycline—ALB—hypertension	8.96e-05	0.0454	CrCbGaD
Minocycline—VEGFA—Enalapril—Trandolapril—hypertension	8.65e-05	0.0289	CbGdCrCtD
Minocycline—VEGFA—Pindolol—Acebutolol—hypertension	7.98e-05	0.0266	CbGdCrCtD
Minocycline—VEGFA—Pindolol—Metoprolol—hypertension	7.25e-05	0.0242	CbGdCrCtD
Minocycline—VEGFA—Pindolol—Esmolol—hypertension	6.87e-05	0.0229	CbGdCrCtD
Minocycline—VEGFA—Enalapril—Lisinopril—hypertension	6.77e-05	0.0226	CbGdCrCtD
Minocycline—VEGFA—Enalapril—Ramipril—hypertension	6.56e-05	0.0219	CbGdCrCtD
Minocycline—CYCS—Triflupromazine—Diltiazem—hypertension	6.23e-05	0.0208	CbGdCrCtD
Minocycline—VEGFA—Pindolol—Betaxolol—hypertension	6.05e-05	0.0202	CbGdCrCtD
Minocycline—VEGFA—Pindolol—Propranolol—hypertension	4.1e-05	0.0137	CbGdCrCtD
Minocycline—CYCS—Metabolism—PTGS2—hypertension	3.1e-06	2.39e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—hypertension	3.09e-06	2.39e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—EP300—hypertension	3.09e-06	2.39e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KNG1—hypertension	3.09e-06	2.39e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—BCL2—hypertension	3.08e-06	2.38e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRL—hypertension	3.07e-06	2.37e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGTR1—hypertension	3.07e-06	2.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRA2A—hypertension	3.07e-06	2.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—SRC—hypertension	3.06e-06	2.37e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CALM1—hypertension	3.06e-06	2.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PLAT—hypertension	3.05e-06	2.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GHRL—hypertension	3.05e-06	2.36e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LEP—hypertension	3.05e-06	2.36e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOE—hypertension	3.05e-06	2.36e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HDAC1—hypertension	3.03e-06	2.34e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STK11—hypertension	3.03e-06	2.34e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CAV1—hypertension	3.02e-06	2.34e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CALCA—hypertension	3.02e-06	2.33e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOA1—hypertension	3.01e-06	2.33e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—RELA—hypertension	3.01e-06	2.33e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SRC—hypertension	3e-06	2.32e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL10—hypertension	3e-06	2.32e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PLG—hypertension	2.99e-06	2.31e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—hypertension	2.99e-06	2.31e-05	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ALB—hypertension	2.99e-06	2.31e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KDR—hypertension	2.99e-06	2.31e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MTOR—hypertension	2.95e-06	2.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BDKRB2—hypertension	2.95e-06	2.28e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—hypertension	2.94e-06	2.28e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARA—hypertension	2.94e-06	2.27e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRBK1—hypertension	2.91e-06	2.25e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB2—hypertension	2.91e-06	2.25e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CNR1—hypertension	2.89e-06	2.24e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—hypertension	2.89e-06	2.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKCE—hypertension	2.88e-06	2.22e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRKCB—hypertension	2.88e-06	2.22e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—F2—hypertension	2.88e-06	2.22e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FN1—hypertension	2.88e-06	2.22e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CALM2—hypertension	2.86e-06	2.21e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AGT—hypertension	2.84e-06	2.2e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VAV3—hypertension	2.84e-06	2.2e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDGFA—hypertension	2.84e-06	2.2e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR7—hypertension	2.82e-06	2.18e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD2—hypertension	2.82e-06	2.18e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOTCH1—hypertension	2.81e-06	2.18e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFBR2—hypertension	2.8e-06	2.16e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CALM1—hypertension	2.8e-06	2.16e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GCG—hypertension	2.79e-06	2.16e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTPN1—hypertension	2.79e-06	2.16e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOE—hypertension	2.79e-06	2.15e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNB3—hypertension	2.77e-06	2.14e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CAV1—hypertension	2.76e-06	2.13e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOA1—hypertension	2.75e-06	2.13e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH2—hypertension	2.74e-06	2.12e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KL—hypertension	2.74e-06	2.12e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—hypertension	2.74e-06	2.12e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AVP—hypertension	2.74e-06	2.12e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNAS—hypertension	2.7e-06	2.09e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTEN—hypertension	2.7e-06	2.09e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ITGAV—hypertension	2.69e-06	2.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NGFR—hypertension	2.69e-06	2.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—hypertension	2.69e-06	2.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—hypertension	2.68e-06	2.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KNG1—hypertension	2.68e-06	2.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGTR1—hypertension	2.67e-06	2.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRL—hypertension	2.67e-06	2.06e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOB—hypertension	2.65e-06	2.04e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTK2—hypertension	2.63e-06	2.04e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HDAC1—hypertension	2.63e-06	2.03e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STK11—hypertension	2.63e-06	2.03e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—POMC—hypertension	2.62e-06	2.02e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—INS—hypertension	2.61e-06	2.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL10—hypertension	2.6e-06	2.01e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EDN1—hypertension	2.6e-06	2.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PLG—hypertension	2.6e-06	2.01e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL5—hypertension	2.58e-06	2e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—EP300—hypertension	2.58e-06	1.99e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL2—hypertension	2.56e-06	1.98e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDKN1A—hypertension	2.56e-06	1.98e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—hypertension	2.56e-06	1.98e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTEN—hypertension	2.55e-06	1.97e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—hypertension	2.55e-06	1.97e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB2—hypertension	2.53e-06	1.95e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LPL—hypertension	2.53e-06	1.95e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1—hypertension	2.52e-06	1.95e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT2—hypertension	2.52e-06	1.95e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—H2AFX—hypertension	2.51e-06	1.94e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RPS6KB1—hypertension	2.5e-06	1.93e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDGFRB—hypertension	2.5e-06	1.93e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKCE—hypertension	2.5e-06	1.93e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MAPK8—hypertension	2.5e-06	1.93e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ALB—hypertension	2.5e-06	1.93e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADCY5—hypertension	2.47e-06	1.91e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDGFA—hypertension	2.47e-06	1.91e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—VAV3—hypertension	2.47e-06	1.91e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKCG—hypertension	2.46e-06	1.9e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ITGB3—hypertension	2.44e-06	1.89e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKCA—hypertension	2.44e-06	1.89e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—EP300—hypertension	2.43e-06	1.88e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFBR2—hypertension	2.43e-06	1.88e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARG—hypertension	2.43e-06	1.87e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—YWHAZ—hypertension	2.42e-06	1.87e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNB3—hypertension	2.41e-06	1.86e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SERPINE1—hypertension	2.39e-06	1.85e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—POMC—hypertension	2.39e-06	1.85e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NGF—hypertension	2.39e-06	1.85e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SPP1—hypertension	2.39e-06	1.85e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—INS—hypertension	2.38e-06	1.84e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—hypertension	2.38e-06	1.84e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AVP—hypertension	2.38e-06	1.84e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—SRC—hypertension	2.37e-06	1.83e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—AKT1—hypertension	2.35e-06	1.82e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNAS—hypertension	2.34e-06	1.81e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKCD—hypertension	2.33e-06	1.8e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR5—hypertension	2.33e-06	1.8e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF2—hypertension	2.32e-06	1.79e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RHOA—hypertension	2.31e-06	1.78e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOB—hypertension	2.3e-06	1.77e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTK2—hypertension	2.29e-06	1.77e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOS3—hypertension	2.28e-06	1.77e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3R1—hypertension	2.28e-06	1.77e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2A—hypertension	2.28e-06	1.76e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—C3—hypertension	2.27e-06	1.76e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EDN1—hypertension	2.26e-06	1.75e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL5—hypertension	2.24e-06	1.73e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDGFB—hypertension	2.21e-06	1.71e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—hypertension	2.21e-06	1.71e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGFR1—hypertension	2.2e-06	1.7e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LPL—hypertension	2.19e-06	1.69e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—AKT1—hypertension	2.19e-06	1.69e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALB—hypertension	2.18e-06	1.69e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—H2AFX—hypertension	2.18e-06	1.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RPS6KB1—hypertension	2.17e-06	1.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDGFRB—hypertension	2.17e-06	1.68e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HIF1A—hypertension	2.17e-06	1.68e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGT—hypertension	2.16e-06	1.67e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RELA—hypertension	2.15e-06	1.66e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADCY5—hypertension	2.15e-06	1.66e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKCG—hypertension	2.13e-06	1.65e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CALM1—hypertension	2.12e-06	1.64e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ITGB3—hypertension	2.12e-06	1.64e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKCA—hypertension	2.12e-06	1.64e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOE—hypertension	2.12e-06	1.64e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LEP—hypertension	2.12e-06	1.64e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MTOR—hypertension	2.11e-06	1.63e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—YWHAZ—hypertension	2.1e-06	1.62e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CAV1—hypertension	2.1e-06	1.62e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOA1—hypertension	2.09e-06	1.62e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3R1—hypertension	2.09e-06	1.61e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NOS3—hypertension	2.09e-06	1.61e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NGF—hypertension	2.08e-06	1.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SPP1—hypertension	2.08e-06	1.6e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KDR—hypertension	2.07e-06	1.6e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—hypertension	2.07e-06	1.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—hypertension	2.06e-06	1.59e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL8—hypertension	2.03e-06	1.57e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR5—hypertension	2.02e-06	1.56e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKCD—hypertension	2.02e-06	1.56e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKCB—hypertension	2e-06	1.54e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—F2—hypertension	2e-06	1.54e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FN1—hypertension	2e-06	1.54e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2A—hypertension	1.98e-06	1.53e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—C3—hypertension	1.97e-06	1.53e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOTCH1—hypertension	1.95e-06	1.51e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDGFB—hypertension	1.92e-06	1.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGFR1—hypertension	1.91e-06	1.48e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—hypertension	1.91e-06	1.47e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—AKT1—hypertension	1.9e-06	1.47e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HIF1A—hypertension	1.88e-06	1.45e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGT—hypertension	1.88e-06	1.45e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—AKT1—hypertension	1.87e-06	1.44e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CALM1—hypertension	1.84e-06	1.43e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LEP—hypertension	1.84e-06	1.42e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOE—hypertension	1.84e-06	1.42e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—hypertension	1.83e-06	1.42e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDKN1A—hypertension	1.83e-06	1.41e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTEN—hypertension	1.82e-06	1.41e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CAV1—hypertension	1.82e-06	1.41e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—POMC—hypertension	1.82e-06	1.41e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOA1—hypertension	1.82e-06	1.4e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—INS—hypertension	1.81e-06	1.4e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KDR—hypertension	1.8e-06	1.39e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAPK8—hypertension	1.78e-06	1.38e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL2—hypertension	1.78e-06	1.38e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1—hypertension	1.75e-06	1.35e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT2—hypertension	1.75e-06	1.35e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EP300—hypertension	1.74e-06	1.34e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FN1—hypertension	1.73e-06	1.34e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKCB—hypertension	1.73e-06	1.34e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—F2—hypertension	1.73e-06	1.34e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH1—hypertension	1.7e-06	1.31e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SRC—hypertension	1.69e-06	1.31e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTEN—hypertension	1.66e-06	1.29e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SERPINE1—hypertension	1.66e-06	1.28e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—hypertension	1.65e-06	1.27e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF2—hypertension	1.61e-06	1.24e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RHOA—hypertension	1.6e-06	1.24e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—hypertension	1.59e-06	1.23e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—EP300—hypertension	1.59e-06	1.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3R1—hypertension	1.59e-06	1.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOS3—hypertension	1.59e-06	1.23e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—POMC—hypertension	1.58e-06	1.22e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—INS—hypertension	1.57e-06	1.21e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKT1—hypertension	1.56e-06	1.2e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL2—hypertension	1.54e-06	1.19e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1—hypertension	1.52e-06	1.17e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT2—hypertension	1.52e-06	1.17e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MYC—hypertension	1.51e-06	1.17e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—hypertension	1.51e-06	1.17e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RELA—hypertension	1.49e-06	1.15e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—hypertension	1.48e-06	1.14e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT1—hypertension	1.47e-06	1.14e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MTOR—hypertension	1.46e-06	1.13e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SERPINE1—hypertension	1.44e-06	1.11e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL8—hypertension	1.41e-06	1.09e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF2—hypertension	1.4e-06	1.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RHOA—hypertension	1.39e-06	1.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOS3—hypertension	1.38e-06	1.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3R1—hypertension	1.38e-06	1.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RELA—hypertension	1.3e-06	1e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MTOR—hypertension	1.27e-06	9.82e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDKN1A—hypertension	1.27e-06	9.8e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTEN—hypertension	1.27e-06	9.78e-06	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—hypertension	1.24e-06	9.61e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAPK8—hypertension	1.24e-06	9.56e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL8—hypertension	1.22e-06	9.44e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EP300—hypertension	1.21e-06	9.32e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SRC—hypertension	1.17e-06	9.07e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—hypertension	1.14e-06	8.83e-06	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—hypertension	1.14e-06	8.8e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—hypertension	1.1e-06	8.54e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDKN1A—hypertension	1.1e-06	8.51e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTEN—hypertension	1.1e-06	8.49e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAPK8—hypertension	1.07e-06	8.3e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MYC—hypertension	1.05e-06	8.12e-06	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT1—hypertension	1.05e-06	8.12e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—hypertension	1.05e-06	8.11e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EP300—hypertension	1.05e-06	8.09e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—hypertension	1.03e-06	7.95e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SRC—hypertension	1.02e-06	7.87e-06	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKT1—hypertension	9.59e-07	7.41e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MYC—hypertension	9.13e-07	7.05e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—hypertension	9.1e-07	7.04e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—hypertension	8.93e-07	6.9e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—hypertension	8.63e-07	6.67e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—hypertension	7.9e-07	6.11e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—hypertension	7.5e-07	5.79e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT1—hypertension	7.29e-07	5.63e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—hypertension	6.86e-07	5.3e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT1—hypertension	6.33e-07	4.89e-06	CbGpPWpGaD
